A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy
Elite suppressors are untreated individuals with human immunodeficiency virus type 1 (HIV-1) infection who maintain viral loads
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2008-07, Vol.47 (1), p.102-104 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 104 |
|---|---|
| container_issue | 1 |
| container_start_page | 102 |
| container_title | Clinical infectious diseases |
| container_volume | 47 |
| creator | Dinoso, Jason B. Kim, Scott Y. Siliciano, Robert F. Blankson, Joel N. |
| description | Elite suppressors are untreated individuals with human immunodeficiency virus type 1 (HIV-1) infection who maintain viral loads |
| doi_str_mv | 10.1086/588791 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2564994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>40307578</jstor_id><oup_id>10.1086/588791</oup_id><sourcerecordid>40307578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-67443c8c3d90a7767b028bb2ceff007f792262f8f47b57a910ebd04647ccc4913</originalsourceid><addsrcrecordid>eNqFkt1u0zAYhiMEYmPAHYAMEpwF7Pj_BKlU21qpEtIYA-3EchxndUnjYDuFnnEPu0OuhJRWLSAhjvxZ76P3-82yxwi-QlCw11QILtGd7BhRzHNGJbo7xJCKnAgsjrIHMS4gREhAej87QoJIwiA7zm5HYOyXnQ4u-hb4Gly5oBsw87qKoLTpq7UtmEyvcvTj--20ra1JtgKnjUsWvO-7LtgYfYhAtxWYtpVbuarXTQQf5x5cWGPd6sBt4om7mTdrMDJp8xu1yQWbgl_9yno5t0F364fZvXrwsI9270n24ez0cjzJZ-_Op-PRLDcUi5QzTgg2wuBKQs054yUsRFkWxtY1hLzmsihYUYua8JJyLRG0ZQUJI9wYQyTCJ9mbrW_Xl0tbGdumoQrVBbfUYa28dupPpXVzdeNXqqCMSEkGg5c7g-C_9DYmtXTR2KbRrfV9VBwxLCBn_wULhCUlQgzg87_Ahe9DO0xhYKRkEJPi4GaCjzHYel8ygmpzDWp7DQP49PcGD9hu_QPwYgfoaHRTB90aF_dcAYcJ4wIP3LMt5_vu38mebJlFTD7sKQIx5JRvWsu3uovJftvrOnxWjGNO1eTTtbq4fkvg-ZlQBP8E9HLhHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219960342</pqid></control><display><type>article</type><title>A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Dinoso, Jason B. ; Kim, Scott Y. ; Siliciano, Robert F. ; Blankson, Joel N.</creator><creatorcontrib>Dinoso, Jason B. ; Kim, Scott Y. ; Siliciano, Robert F. ; Blankson, Joel N.</creatorcontrib><description>Elite suppressors are untreated individuals with human immunodeficiency virus type 1 (HIV-1) infection who maintain viral loads <50 copies/mL. Using a single-copy assay, we show that there is no statistically significant difference between the proportions of elite suppressors and patients receiving suppressive highly active antiretroviral therapy who have viral loads of <1 copy/mL.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/588791</identifier><identifier>PMID: 18494606</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiretroviral drugs ; Antiretroviral Therapy, Highly Active ; Antiviral agents ; Biological and medical sciences ; Blood plasma ; Brief Reports ; Drug therapy ; Highly active antiretroviral therapy ; HIV ; HIV 1 ; HIV Infections - drug therapy ; HIV Infections - immunology ; HIV Infections - virology ; HIV Long-Term Survivors ; HIV-1 - isolation & purification ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infections ; Infectious diseases ; Medical sciences ; Pharmacology. Drug treatments ; Proportions ; Statistical significance ; T lymphocytes ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral Load ; Viremia ; Virology ; Viruses</subject><ispartof>Clinical infectious diseases, 2008-07, Vol.47 (1), p.102-104</ispartof><rights>Copyright 2008 Infectious Diseases Society of America</rights><rights>2008 by the Infectious Diseases Society of America 2008</rights><rights>2008 INIST-CNRS</rights><rights>Copyright University of Chicago, acting through its Press Jul 1, 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-67443c8c3d90a7767b028bb2ceff007f792262f8f47b57a910ebd04647ccc4913</citedby><cites>FETCH-LOGICAL-c538t-67443c8c3d90a7767b028bb2ceff007f792262f8f47b57a910ebd04647ccc4913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/40307578$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/40307578$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,27903,27904,57995,58228</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20443323$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18494606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dinoso, Jason B.</creatorcontrib><creatorcontrib>Kim, Scott Y.</creatorcontrib><creatorcontrib>Siliciano, Robert F.</creatorcontrib><creatorcontrib>Blankson, Joel N.</creatorcontrib><title>A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Elite suppressors are untreated individuals with human immunodeficiency virus type 1 (HIV-1) infection who maintain viral loads <50 copies/mL. Using a single-copy assay, we show that there is no statistically significant difference between the proportions of elite suppressors and patients receiving suppressive highly active antiretroviral therapy who have viral loads of <1 copy/mL.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Blood plasma</subject><subject>Brief Reports</subject><subject>Drug therapy</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV 1</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV Long-Term Survivors</subject><subject>HIV-1 - isolation & purification</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Proportions</subject><subject>Statistical significance</subject><subject>T lymphocytes</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral Load</subject><subject>Viremia</subject><subject>Virology</subject><subject>Viruses</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkt1u0zAYhiMEYmPAHYAMEpwF7Pj_BKlU21qpEtIYA-3EchxndUnjYDuFnnEPu0OuhJRWLSAhjvxZ76P3-82yxwi-QlCw11QILtGd7BhRzHNGJbo7xJCKnAgsjrIHMS4gREhAej87QoJIwiA7zm5HYOyXnQ4u-hb4Gly5oBsw87qKoLTpq7UtmEyvcvTj--20ra1JtgKnjUsWvO-7LtgYfYhAtxWYtpVbuarXTQQf5x5cWGPd6sBt4om7mTdrMDJp8xu1yQWbgl_9yno5t0F364fZvXrwsI9270n24ez0cjzJZ-_Op-PRLDcUi5QzTgg2wuBKQs054yUsRFkWxtY1hLzmsihYUYua8JJyLRG0ZQUJI9wYQyTCJ9mbrW_Xl0tbGdumoQrVBbfUYa28dupPpXVzdeNXqqCMSEkGg5c7g-C_9DYmtXTR2KbRrfV9VBwxLCBn_wULhCUlQgzg87_Ahe9DO0xhYKRkEJPi4GaCjzHYel8ygmpzDWp7DQP49PcGD9hu_QPwYgfoaHRTB90aF_dcAYcJ4wIP3LMt5_vu38mebJlFTD7sKQIx5JRvWsu3uovJftvrOnxWjGNO1eTTtbq4fkvg-ZlQBP8E9HLhHw</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>Dinoso, Jason B.</creator><creator>Kim, Scott Y.</creator><creator>Siliciano, Robert F.</creator><creator>Blankson, Joel N.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080701</creationdate><title>A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy</title><author>Dinoso, Jason B. ; Kim, Scott Y. ; Siliciano, Robert F. ; Blankson, Joel N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-67443c8c3d90a7767b028bb2ceff007f792262f8f47b57a910ebd04647ccc4913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Blood plasma</topic><topic>Brief Reports</topic><topic>Drug therapy</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV 1</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV Long-Term Survivors</topic><topic>HIV-1 - isolation & purification</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Proportions</topic><topic>Statistical significance</topic><topic>T lymphocytes</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral Load</topic><topic>Viremia</topic><topic>Virology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dinoso, Jason B.</creatorcontrib><creatorcontrib>Kim, Scott Y.</creatorcontrib><creatorcontrib>Siliciano, Robert F.</creatorcontrib><creatorcontrib>Blankson, Joel N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dinoso, Jason B.</au><au>Kim, Scott Y.</au><au>Siliciano, Robert F.</au><au>Blankson, Joel N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>47</volume><issue>1</issue><spage>102</spage><epage>104</epage><pages>102-104</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Elite suppressors are untreated individuals with human immunodeficiency virus type 1 (HIV-1) infection who maintain viral loads <50 copies/mL. Using a single-copy assay, we show that there is no statistically significant difference between the proportions of elite suppressors and patients receiving suppressive highly active antiretroviral therapy who have viral loads of <1 copy/mL.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>18494606</pmid><doi>10.1086/588791</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2008-07, Vol.47 (1), p.102-104 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2564994 |
| source | Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral drugs Antiretroviral Therapy, Highly Active Antiviral agents Biological and medical sciences Blood plasma Brief Reports Drug therapy Highly active antiretroviral therapy HIV HIV 1 HIV Infections - drug therapy HIV Infections - immunology HIV Infections - virology HIV Long-Term Survivors HIV-1 - isolation & purification Human immunodeficiency virus Human immunodeficiency virus 1 Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infections Infectious diseases Medical sciences Pharmacology. Drug treatments Proportions Statistical significance T lymphocytes Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral Load Viremia Virology Viruses |
| title | A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A20%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Comparison%20of%20Viral%20Loads%20between%20HIV-1%E2%80%93Infected%20Elite%20Suppressors%20and%20Individuals%20Who%20Receive%20Suppressive%20Highly%20Active%20Antiretroviral%20Therapy&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Dinoso,%20Jason%20B.&rft.date=2008-07-01&rft.volume=47&rft.issue=1&rft.spage=102&rft.epage=104&rft.pages=102-104&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/588791&rft_dat=%3Cjstor_pubme%3E40307578%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219960342&rft_id=info:pmid/18494606&rft_jstor_id=40307578&rft_oup_id=10.1086/588791&rfr_iscdi=true |